@inproceedings{inproceedings, title  = {{Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study}},

 url = {{}},

 year = {{1998}},

 month = {{4}},

 author = {{van Hout BA and Bowman L and Zelinger DJ and Simoons ML}},

 volume = {{19}},

 journal = {{EUROPEAN HEART JOURNAL}},

 pages = {{D59-D66}},

 note = {{Accessed on 2025/04/04}}}